Article contents
Anthracycline-related acute cardiotoxicity in a very young Omani patient with acute myeloid leukaemia
Published online by Cambridge University Press: 24 November 2020
Abstract
Anthracycline-related cardiomyopathy is of concern in children treated for acute myeloid leukemia (AML). Risk is dose-dependent, increasing with higher doses. We aim to highlight the risk of early-onset cardiotoxicity with low-cumulative anthracycline dose in a young Omani boy with AML. We conclude in the presence of other known risk factors for cardiac dysfunction, there is probably no risk-free anthracycline dose.
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2020. Published by Cambridge University Press
References
- 1
- Cited by